APA

Houot R., Le Gouill S., Ojeda Uribe M., Mounier C., Courby S., Dartigeas C., Bouabdallah K., Alexis Vigier M., Moles M. P., Tournilhac O., Arakelyan N., Rodon P., El Yamani A., Sutton L., Fornecker L., Assouline D., Harousseau J. L., Maisonneuve H., Caulet-Maugendre S. & Gressin R. (20120920). Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Houot R, Le Gouill S, Ojeda Uribe M, Mounier C, Courby S, Dartigeas C, Bouabdallah K, Alexis Vigier M, Moles M P, Tournilhac O, Arakelyan N, Rodon P, El Yamani A, Sutton L, Fornecker L, Assouline D, Harousseau J L, Maisonneuve H, Caulet-Maugendre S and Gressin R. 20120920. Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Houot R., Le Gouill S., Ojeda Uribe M., Mounier C., Courby S., Dartigeas C., Bouabdallah K., Alexis Vigier M., Moles M. P., Tournilhac O., Arakelyan N., Rodon P., El Yamani A., Sutton L., Fornecker L., Assouline D., Harousseau J. L., Maisonneuve H., Caulet-Maugendre S. and Gressin R. (20120920). Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Houot R, Le Gouill S, Ojeda Uribe M, Mounier C, Courby S, Dartigeas C, Bouabdallah K, Alexis Vigier M, Moles M P, Tournilhac O, Arakelyan N, Rodon P, El Yamani A, Sutton L, Fornecker L, Assouline D, Harousseau J L, Maisonneuve H, Caulet-Maugendre S and Gressin R. Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS. : Annals of oncology : official journal of the European Society for Medical Oncology. 20120920.